atomoxetine hydrochloride has been researched along with amphetamine in 53 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 15 (28.30) | 29.6817 |
| 2010's | 31 (58.49) | 24.3611 |
| 2020's | 7 (13.21) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Biederman, J; Faraone, SV; Spencer, TJ; Wilens, TE | 1 |
| Dodson, WW | 1 |
| Dougherty, M; McDonnell, MA | 1 |
| Allen, AJ; Bangs, ME; Cherlin, EA; Duesenberg, DA; Feldman, PD; Kelsey, DK; Quintana, H; Ramsey, JL | 1 |
| Goodman, DW | 1 |
| Asheim, H; Furu, K; Johansen, K; Nilsen, KB | 1 |
| Gualtieri, CT; Johnson, LG | 1 |
| DeVane, CL; Donovan, JL; Gibson, BB; Jiang, Y; Markowitz, JS; Wang, JS; Zhu, HJ | 1 |
| Adler, LA; Michelson, D; Moore, RJ; Spencer, TJ; Williams, DW | 1 |
| Heal, DJ; Kulkarni, RS; Rowley, HL; Smith, SL | 1 |
| Sewell, RA; Sofuoglu, M | 1 |
| Kay, GG; Michaels, MA; Pakull, B | 1 |
| Abe, M; Baba, A; Hashimoto, H; Köves, K; Kubo, M; Kuroda, M; Shibasaki, Y; Shintani, N; Tsuchida, R | 1 |
| Dopheide, JA; Pliszka, SR | 1 |
| Clement, HW; Gebhardt, S; Heiser, P; Krieg, JC; Schmidt, AJ; Schulz, E | 1 |
| Cheetham, SC; Heal, DJ; Smith, SL | 1 |
| Froehlich, TE; McGough, JJ; Stein, MA | 1 |
| Christensen, L; Harley, C; Hodgkins, P; Sasané, R; Tetali, S | 1 |
| Clement, HW; Gebhardt, S; Heiser, P; Hemmeter, UM; Kircher, T; Krieg, JC; Schmidt, AJ; Schulz, E | 1 |
| Bidwell, LC; Kollins, SH; McClernon, FJ | 1 |
| Barner, JC; Khoza, S; Oladapo, A | 1 |
| Baarendse, PJ; Vanderschuren, LJ | 1 |
| Broos, N; de Geus, EJ; de Vries, TJ; Goudriaan, AE; Ham, J; Kostelijk, L; Lam, T; Pattij, T; Schmaal, L; Schoffelmeer, AN; Stoop, N; van den Brink, W; Veltman, DJ; Weierink, L; Wiskerke, J | 1 |
| Almarsdóttir, AB; Baldursson, G; Halldórsson, M; Hernández-Diaz, S; Huybrechts, KF; Jónsdóttir, S; Ólafsson, Ö; Rothman, KJ; Valdimarsdóttir, UA; Zoëga, H | 1 |
| Faraone, SV; Fredriksen, M; Haavik, J; Halmøy, A | 1 |
| Cassidy, E; Dommett, EJ; Turner, M; Wilding, E | 1 |
| Terry, AV; Wilson, CA | 1 |
| Beaulieu, JM; Del'Guidice, T; Escoffier, G; Etiévant, A; Lemasson, M; Magno, LA; Manta, S; Roman, FS | 1 |
| Achterberg, EJ; Schoffelmeer, AN; Schrama, L; Siviy, SM; Trezza, V; Vanderschuren, LJ | 1 |
| Anagnostaras, SG; Carmack, SA; Howell, KK; Rasaei, K; Reas, ET | 1 |
| Bardo, MT; Charnigo, R; Gipson, CD; Meyer, AC; Perry, JL; Yates, JR | 1 |
| Chen, Q; D'Onofrio, BM; Larsson, H; Lichtenstein, P; Runeson, B; Sjölander, A | 1 |
| Heyd, A; Nohr, FI; Norum, J; Olsen, AI; Totth, A | 1 |
| McLennan, JD; Vallerand, IA; Wagner, DJ | 1 |
| Dahl, AA; Fredriksen, M; Haavik, J; Klungsøyr, O; Martinsen, EW; Peleikis, DE | 1 |
| Arponen, E; Babalola, PA; Farde, L; Finnema, SJ; Grimwood, S; Haaparanta-Solin, M; Halldin, C; Hughes, ZA; Marjamäki, P; Nakao, R; Pohjanoksa, K; Sallinen, J; Scheinin, M; Solin, O; Stepanov, V; Varnäs, K; Varrone, A; Vuorilehto, L | 1 |
| Clark, L; Murch, WS; Silveira, MM; Winstanley, CA | 1 |
| Merrill, RM; Palmer, CA; Thygerson, SM | 1 |
| Adams, WK; Kaur, S; Lam, FC; Muthukrishna, M; Riparip, LK; Rosi, S; Vonder Haar, C; Winstanley, CA | 1 |
| Bahmanyar, S; Furu, K; Karlstad, Ø; Kieler, H; Martikainen, JE; Pottegård, A; Zoëga, H | 1 |
| Borges Dos Reis, C; Chierrito de Oliveira, D; Cristina Conegero Sanches, A; Fernandez-Llimos, F; Guerrero de Sousa, P; Maria Steimbach, L; Pontarolo, R; Tonin, FS; Virtuoso, S | 1 |
| Bateman, BT; Cohen, JM; Desai, RJ; Gray, KJ; Hernández-Díaz, S; Huybrechts, KF; Mogun, H; Park, Y; Patorno, E | 1 |
| Casavant, MJ; Chounthirath, T; Hodges, NL; King, SA; Smith, GA; Spiller, HA | 1 |
| Andreasen, JT; Caballero-Puntiverio, M; Dietz, AG; Grupe, M; Larsen, CW; Lerdrup, LS | 1 |
| France, CP; Maguire, DR | 1 |
| Andreasen, JT; Arvastson, L; Aznar, S; Caballero-Puntiverio, M; Lerdrup, LS | 1 |
| Shen, G; Shi, WX | 1 |
| Bai, Z; Charach, A; Chojecki, D; Eagles, C; Elliott, J; Hossain, A; Hsieh, SC; Husereau, D; Johnston, A; Kelly, SE; Mamdani, M; Skidmore, B; Tsakonas, E; Wells, GA | 1 |
| Andreasen, JT; Arvastson, L; Caballero-Puntiverio, M; Klem, L; Lerdrup, L; Prichardt, S | 1 |
| Gether, U; Hervig, ME; Petersen, A; Robbins, TW; Toschi, C; Vangkilde, S | 1 |
| Surman, CBH; Walsh, DM | 1 |
| Gillies, D; Leach, MJ; Perez Algorta, G | 1 |
15 review(s) available for atomoxetine hydrochloride and amphetamine
| Article | Year |
|---|---|
Novel treatments for attention-deficit/hyperactivity disorder in children.
Topics: Adolescent; Age Factors; Amphetamine; Antidepressive Agents, Tricyclic; Antihypertensive Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants; Child; Dextroamphetamine; Drug Administration Schedule; Humans; Meta-Analysis as Topic; Monoamine Oxidase Inhibitors; Propylamines; Psychiatric Status Rating Scales; Research Design; Selective Serotonin Reuptake Inhibitors | 2002 |
Pharmacotherapy of adult ADHD.
Topics: Adolescent; Adult; Age Factors; Amphetamine; Antidepressive Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Central Nervous System Stimulants; Child; Combined Modality Therapy; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Methylphenidate; Propylamines; Treatment Outcome | 2005 |
Righting a troubled course. Diagnosing and treating ADHD in adults.
Topics: Adult; Age Factors; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Comorbidity; Humans; Methylphenidate; Nurse Practitioners; Nursing Assessment; Practice Guidelines as Topic; Primary Health Care; Propylamines | 2005 |
The consequences of attention-deficit/hyperactivity disorder in adults.
Topics: Achievement; Adult; Age Factors; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Disease Progression; Female; Health Care Costs; Humans; Impulsive Behavior; Male; Mental Disorders; Methylphenidate; Propylamines; Quality of Life; Sex Distribution; Social Adjustment; Substance-Related Disorders | 2007 |
New perspectives from microdialysis studies in freely-moving, spontaneously hypertensive rats on the pharmacology of drugs for the treatment of ADHD.
Topics: Amphetamine; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Disease Models, Animal; Dopamine; Humans; Methylphenidate; Microdialysis; Norepinephrine; Propylamines; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 2008 |
Norepinephrine and stimulant addiction.
Topics: Adrenergic Agonists; Amphetamine; Arousal; Atomoxetine Hydrochloride; Attention; Central Nervous System Stimulants; Cocaine; Dopamine; Humans; Methamphetamine; Norepinephrine; Propylamines; Substance-Related Disorders | 2009 |
Attention-deficit-hyperactivity disorder: an update.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Amphetamine; Antidepressive Agents, Second-Generation; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Case-Control Studies; Central Nervous System Stimulants; Child; Conduct Disorder; Follow-Up Studies; Humans; Juvenile Delinquency; Longitudinal Studies; Methylphenidate; Patient Compliance; Prescriptions; Prevalence; Propylamines; Substance-Related Disorders; Time Factors; Treatment Outcome; United States | 2009 |
The neuropharmacology of ADHD drugs in vivo: insights on efficacy and safety.
Topics: Adrenergic Uptake Inhibitors; Amphetamine; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Brain; Catecholamines; Central Nervous System Stimulants; Dopamine Agents; Humans; Methylphenidate; Propylamines; Stereoisomerism; Substance-Related Disorders | 2009 |
Progress and promise of attention-deficit hyperactivity disorder pharmacogenetics.
Topics: Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Catechol O-Methyltransferase; Central Nervous System Stimulants; Dopamine Plasma Membrane Transport Proteins; Humans; Inactivation, Metabolic; Methylphenidate; Norepinephrine Plasma Membrane Transport Proteins; Propylamines; Receptors, Adrenergic, alpha-2; Receptors, Dopamine D4; Receptors, Dopamine D5; Synaptosomal-Associated Protein 25 | 2010 |
Cognitive enhancers for the treatment of ADHD.
Topics: Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Cholinergic Agents; Clonidine; Cognition; Executive Function; Guanfacine; Humans; Intelligence; Methylphenidate; Nootropic Agents; Propylamines; Reward; Social Behavior | 2011 |
Long-term efficacy and safety of treatment with stimulants and atomoxetine in adult ADHD: a review of controlled and naturalistic studies.
Topics: Adrenergic Uptake Inhibitors; Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cross-Sectional Studies; Humans; Longitudinal Studies; Methylphenidate; Propylamines; Randomized Controlled Trials as Topic | 2013 |
Safety of Treatments for ADHD in Adults: Pairwise and Network Meta-Analyses.
Topics: Adrenergic Uptake Inhibitors; Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Databases, Factual; Humans; Methylphenidate; Network Meta-Analysis; Odds Ratio; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Wakefulness | 2019 |
Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis.
Topics: Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bayes Theorem; Bupropion; Central Nervous System Stimulants; Dextroamphetamine; Drug-Related Side Effects and Adverse Reactions; Female; Guanfacine; Humans; Lisdexamfetamine Dimesylate; Male; Methylphenidate; Modafinil; Network Meta-Analysis; Quality of Life; Randomized Controlled Trials as Topic | 2020 |
Do ADHD Treatments Improve Executive Behavior Beyond Core ADHD Symptoms in Adults? Evidence From Systematic Analysis of Clinical Trials.
Topics: Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Executive Function; Humans; Lisdexamfetamine Dimesylate | 2023 |
Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents.
Topics: Adolescent; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Fatty Acids, Omega-3; Fatty Acids, Unsaturated; Humans; Methylphenidate; Quality of Life | 2023 |
4 trial(s) available for atomoxetine hydrochloride and amphetamine
| Article | Year |
|---|---|
Pharmacotherapy of adult ADHD.
Topics: Adolescent; Adult; Age Factors; Amphetamine; Antidepressive Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Central Nervous System Stimulants; Child; Combined Modality Therapy; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Methylphenidate; Propylamines; Treatment Outcome | 2005 |
Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Amphetamine; Analysis of Variance; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Blood Pressure; Central Nervous System Stimulants; Child; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Female; Heart Rate; Humans; Male; Methylphenidate; Pilot Projects; Propylamines; Severity of Illness Index; Treatment Outcome | 2007 |
Medications do not necessarily normalize cognition in ADHD patients.
Topics: Adrenergic Uptake Inhibitors; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Cognition; Cross-Sectional Studies; Female; Humans; Male; Methylphenidate; Neuropsychological Tests; Propylamines | 2008 |
Long-term, open-label safety and efficacy of atomoxetine in adults with ADHD: final report of a 4-year study.
Topics: Adrenergic Uptake Inhibitors; Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Humans; Longitudinal Studies; Methylphenidate; Patient Dropouts; Placebos; Propylamines; Psychiatric Status Rating Scales; Safety; Severity of Illness Index; Treatment Outcome | 2008 |
35 other study(ies) available for atomoxetine hydrochloride and amphetamine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
[Prescribing of stimulants for ADHD in Nordland County].
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Dextroamphetamine; Drug Prescriptions; Drug Utilization; Female; Humans; Male; Methylphenidate; Norway; Propylamines | 2007 |
Interactions of attention-deficit/hyperactivity disorder therapeutic agents with the efflux transporter P-glycoprotein.
Topics: Adenosine Triphosphate; Amphetamine; Animals; Atomoxetine Hydrochloride; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Attention Deficit Disorder with Hyperactivity; Benzhydryl Compounds; Biological Transport; Central Nervous System Stimulants; Cyclosporins; Dose-Response Relationship, Drug; Doxorubicin; Isomerism; LLC-PK1 Cells; Methylphenidate; Modafinil; Propylamines; Reproducibility of Results; Rhodamine 123; Swine; Transfection | 2008 |
Simulated driving changes in young adults with ADHD receiving mixed amphetamine salts extended release and atomoxetine.
Topics: Adrenergic Uptake Inhibitors; Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Automobile Driving; Central Nervous System Stimulants; Computer Simulation; Delayed-Action Preparations; Drug Administration Schedule; Female; Humans; Male; Pilot Projects; Propylamines; Young Adult | 2009 |
An antihyperkinetic action by the serotonin 1A-receptor agonist osemozotan co-administered with psychostimulants or the non-stimulant atomoxetine in mice.
Topics: Adrenergic Uptake Inhibitors; Amphetamine; Animals; Atomoxetine Hydrochloride; Central Nervous System Stimulants; Dioxanes; Dioxoles; Dose-Response Relationship, Drug; Drug Interactions; Hyperkinesis; Male; Methamphetamine; Mice; Mice, Inbred ICR; Piperazines; Propylamines; Pyridines; Receptor, Serotonin, 5-HT1A; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists | 2009 |
Impact of drugs approved for treating ADHD on the cell survival and energy metabolism: an in-vitro study in human neuronal and immune cells.
Topics: Adenosine Triphosphate; Adrenergic Uptake Inhibitors; Amphetamine; Atomoxetine Hydrochloride; Cell Line, Tumor; Cell Survival; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Energy Metabolism; Humans; Methylphenidate; Monocytes; Neuroblastoma; Propylamines; U937 Cells | 2010 |
Pharmacological treatment patterns among patients with attention-deficit/hyperactivity disorder: retrospective claims-based analysis of a managed care population.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Age Factors; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Delayed-Action Preparations; Drug Utilization Review; Female; Health Maintenance Organizations; Humans; Male; Medication Adherence; Methamphetamine; Middle Aged; Practice Patterns, Physicians'; Propylamines; Retrospective Studies; United States | 2010 |
Impact of psychostimulants and atomoxetine on the expression of 8-hydroxyguanine glycosylase 1 in human cells.
Topics: Adrenergic Uptake Inhibitors; Amphetamine; Atomoxetine Hydrochloride; Cell Line; Central Nervous System Stimulants; DNA Glycosylases; Dose-Response Relationship, Drug; Gene Expression Regulation, Enzymologic; Humans; Methylphenidate; Monocytes; Neuroblastoma; Propylamines; RNA, Messenger | 2010 |
ADHD medication use, adherence, persistence and cost among Texas Medicaid children.
Topics: Adolescent; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Female; Humans; Male; Medicaid; Medication Adherence; Methylphenidate; Prodrugs; Propylamines; Regression Analysis; Retrospective Studies; Texas; United States | 2011 |
Dissociable effects of monoamine reuptake inhibitors on distinct forms of impulsive behavior in rats.
Topics: Adrenergic Uptake Inhibitors; Amphetamine; Animals; Animals, Outbred Strains; Atomoxetine Hydrochloride; Choice Behavior; Citalopram; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Impulsive Behavior; Male; Piperazines; Propylamines; Rats; Reaction Time; Selective Serotonin Reuptake Inhibitors; Serial Learning; Time Factors | 2012 |
The relationship between impulsive choice and impulsive action: a cross-species translational study.
Topics: Amphetamine; Animals; Atomoxetine Hydrochloride; Choice Behavior; Humans; Impulsive Behavior; Male; Propylamines; Rats; Research Design; Reward; Self Report; Species Specificity; Young Adult | 2012 |
A population-based study of stimulant drug treatment of ADHD and academic progress in children.
Topics: Achievement; Age Factors; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Educational Measurement; Female; Humans; Iceland; Language Arts; Male; Mathematics; Methylphenidate; Multivariate Analysis; Odds Ratio; Propylamines; Registries; Sex Factors; Treatment Outcome | 2012 |
Effects of atomoxetine on locomotor activity and impulsivity in the spontaneously hypertensive rat.
Topics: Adrenergic Uptake Inhibitors; Amphetamine; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Central Nervous System Sensitization; Disease Models, Animal; Impulsive Behavior; Male; Maze Learning; Motor Activity; Neuropsychological Tests; Propylamines; Rats; Rats, Inbred SHR | 2013 |
Variable maternal stress in rats alters locomotor activity, social behavior, and recognition memory in the adult offspring.
Topics: Adrenergic Uptake Inhibitors; Amphetamine; Animals; Antipsychotic Agents; Atomoxetine Hydrochloride; Behavior, Animal; Benzylidene Compounds; Disease Models, Animal; Female; Humans; Male; Maze Learning; Mental Disorders; Motor Activity; Nicotinic Agonists; Pregnancy; Prenatal Exposure Delayed Effects; Propylamines; Pyridines; Rats; Rats, Sprague-Dawley; Recognition, Psychology; Risperidone; Social Behavior; Stress, Physiological | 2013 |
Dissociations between cognitive and motor effects of psychostimulants and atomoxetine in hyperactive DAT-KO mice.
Topics: Amphetamine; Analysis of Variance; Animals; Atomoxetine Hydrochloride; Central Nervous System Stimulants; Cognition; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Hyperkinesis; Maze Learning; Methamphetamine; Mice; Mice, Inbred C57BL; Motor Activity; Norepinephrine; Propylamines; Psychomotor Performance; Serotonin; Serotonin Agents; Smell | 2014 |
Amphetamine and cocaine suppress social play behavior in rats through distinct mechanisms.
Topics: Adrenergic Agents; Adrenergic alpha-2 Receptor Antagonists; Adrenergic Uptake Inhibitors; Amphetamine; Animals; Atomoxetine Hydrochloride; Behavior, Animal; Cocaine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Exploratory Behavior; Fluoxetine; Flupenthixol; Idazoxan; Male; Motor Activity; Piperazines; Play and Playthings; Propylamines; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Social Behavior | 2014 |
Animal model of methylphenidate's long-term memory-enhancing effects.
Topics: Adrenergic Uptake Inhibitors; Amphetamine; Animals; Atomoxetine Hydrochloride; Bupropion; Central Nervous System Stimulants; Citalopram; Cocaine; Conditioning, Classical; Dose-Response Relationship, Drug; Fear; Female; Locomotion; Male; Maze Learning; Memory, Long-Term; Methylphenidate; Mice; Mice, Inbred C57BL; Nootropic Agents; Propylamines; Reinforcement, Psychology; Selective Serotonin Reuptake Inhibitors; Space Perception | 2014 |
Role of medial prefrontal and orbitofrontal monoamine transporters and receptors in performance in an adjusting delay discounting procedure.
Topics: Adrenergic Uptake Inhibitors; Amphetamine; Animals; Atomoxetine Hydrochloride; Behavior, Addictive; Central Nervous System Stimulants; Choice Behavior; Delay Discounting; Dopamine Agents; Dose-Response Relationship, Drug; Impulsive Behavior; Male; Methylphenidate; Prefrontal Cortex; Propylamines; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D2; Serotonin Agents; Vesicular Monoamine Transport Proteins | 2014 |
Drug treatment for attention-deficit/hyperactivity disorder and suicidal behaviour: register based study.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Female; Humans; Incidence; Longitudinal Studies; Male; Methylphenidate; Middle Aged; Propylamines; Registries; Suicide; Sweden; Young Adult | 2014 |
Medical treatment of children and youths with attention-deficit/hyperactivity disorder (ADHD): a Norwegian Prescription Registry Based Study.
Topics: Adolescent; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Dextroamphetamine; Drug Utilization; Female; Humans; Male; Methylphenidate; Norway; Practice Patterns, Physicians'; Propylamines; Quality of Life; Registries; Residence Characteristics | 2014 |
Treatment receipt and outcomes from a clinic employing the attention-deficit/hyperactivity disorder treatment guideline of the children's medication algorithm project.
Topics: Adolescent; Algorithms; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Female; Humans; Male; Medication Adherence; Methylphenidate; Practice Guidelines as Topic; Propylamines; Treatment Outcome | 2014 |
Effectiveness of one-year pharmacological treatment of adult attention-deficit/hyperactivity disorder (ADHD): an open-label prospective study of time in treatment, dose, side-effects and comorbidity.
Topics: Adrenergic Uptake Inhibitors; Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Medication Adherence; Mental Disorders; Methylphenidate; Propylamines; Prospective Studies; Psychiatric Status Rating Scales; Stress, Psychological; Time Factors; Young Adult | 2014 |
Amphetamine decreases α2C-adrenoceptor binding of [11C]ORM-13070: a PET study in the primate brain.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic Uptake Inhibitors; Amphetamine; Animals; Atomoxetine Hydrochloride; Brain; Central Nervous System Stimulants; Dioxanes; Female; Humans; Imidazoles; Macaca fascicularis; Male; Piperazines; Positron-Emission Tomography; Propylamines; Protein Binding; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Time Factors | 2014 |
Chronic atomoxetine treatment during adolescence does not influence decision-making on a rodent gambling task, but does modulate amphetamine's effect on impulsive action in adulthood.
Topics: Adrenergic Uptake Inhibitors; Amphetamine; Animals; Atomoxetine Hydrochloride; Decision Making; Dose-Response Relationship, Drug; Drug Administration Schedule; Gambling; Impulsive Behavior; Male; Punishment; Rats; Rats, Long-Evans; Reward; Uncertainty | 2016 |
Risk of Injury According to Attention Deficit Hyperactivity Disorder, Comorbid Mental Illness, and Medication Therapy.
Topics: Adolescent; Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Comorbidity; Female; Humans; Infant; Male; Methylphenidate; Middle Aged; Neurotic Disorders; Personality Disorders; Psychoses, Substance-Induced; Psychotic Disorders; United States; Wounds and Injuries; Young Adult | 2016 |
Frontal Traumatic Brain Injury in Rats Causes Long-Lasting Impairments in Impulse Control That Are Differentially Sensitive to Pharmacotherapeutics and Associated with Chronic Neuroinflammation.
Topics: Acute Disease; Adrenergic Uptake Inhibitors; Amantadine; Amphetamine; Animals; Atomoxetine Hydrochloride; Brain Injuries, Traumatic; Central Nervous System Stimulants; Chronic Disease; Disease Models, Animal; Disease Progression; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agents; Frontal Lobe; Male; Motor Activity; Neuroimmunomodulation; Rats, Long-Evans; Severity of Illness Index | 2016 |
Use of drugs for ADHD among adults-a multinational study among 15.8 million adults in the Nordic countries.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Databases, Factual; Dextroamphetamine; Drug Utilization; Female; Humans; Male; Methylphenidate; Middle Aged; Psychotropic Drugs; Scandinavian and Nordic Countries; Young Adult | 2016 |
Placental Complications Associated With Psychostimulant Use in Pregnancy.
Topics: Abruptio Placentae; Adrenergic Uptake Inhibitors; Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cohort Studies; Female; Fetal Growth Retardation; Humans; Methylphenidate; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnancy Trimesters; Premature Birth; Risk Assessment; Statistics as Topic | 2017 |
Pediatric ADHD Medication Exposures Reported to US Poison Control Centers.
Topics: Adolescent; Age Distribution; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Drug Misuse; Humans; Infant; Infant, Newborn; Medication Errors; Methylphenidate; Modafinil; Patient Admission; Poison Control Centers; Retrospective Studies; Suicide, Attempted; United States; Young Adult | 2018 |
Effect of ADHD medication in male C57BL/6J mice performing the rodent Continuous Performance Test.
Topics: Amphetamine; Animals; Atomoxetine Hydrochloride; Attention; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Impulsive Behavior; Male; Methylphenidate; Mice; Mice, Inbred C57BL; Neuropsychological Tests; Rodentia | 2019 |
Effects of amphetamine, methylphenidate, atomoxetine, and morphine in rats responding under an adjusting stop signal reaction time task.
Topics: Amphetamine; Analgesics, Opioid; Animals; Atomoxetine Hydrochloride; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Impulsive Behavior; Male; Methylphenidate; Morphine; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Reaction Time | 2019 |
ADHD medication and the inverted U-shaped curve: A pharmacological study in female mice performing the rodent Continuous Performance Test (rCPT).
Topics: Amphetamine; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Discrimination Learning; Female; Methylphenidate; Mice; Mice, Inbred C57BL; Psychomotor Performance; Rodentia | 2020 |
Amphetamine promotes cortical Up state: Role of adrenergic receptors.
Topics: Amphetamine; Animals; Atomoxetine Hydrochloride; Dextroamphetamine; Dopamine; Male; Methylphenidate; Neurons; Norepinephrine; Prazosin; Prefrontal Cortex; Rats; Receptors, Adrenergic | 2021 |
Assessing the nature of premature responses in the rodent continuous performance test variable intertrial interval schedule using atomoxetine and amphetamine.
Topics: Amphetamine; Animals; Atomoxetine Hydrochloride; Impulsive Behavior; Rodentia | 2023 |
Theory of visual attention (TVA) applied to rats performing the 5-choice serial reaction time task: differential effects of dopaminergic and noradrenergic manipulations.
Topics: Amphetamine; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Dopamine; Humans; Methylphenidate; Norepinephrine; Phenylephrine; Rats; Reaction Time | 2023 |